期刊文献+

瘦素在食管鳞状细胞癌中的表达及其临床意义 被引量:3

Expression and clinical significance of leptin in esophageal squamous cell carcinoma
原文传递
导出
摘要 目的探讨血清瘦素及人体质量指数(BMI)与食管鳞状细胞癌的相关性,为食管癌的防治寻找科学依据。方法收集2009年12月到2010年11月间山西省肿瘤医院胸外二科食管鳞状细胞癌患者47例,以20名健康人为对照,采用酶联免疫吸附法测定血清瘦素水平,分析其与临床病理因素的关系及危险眭。结果鳞状细胞癌患者及健康人血清瘦素水平分别为(13.09±5.94)和(7.58±4.16)ng/ml,差异有统计学意义(t=3.76,P=0.001)。47例患者BMI、清蛋白、淋巴细胞数分别为(25.20±3.14)kg/m^2、(43.58±2.15)g/L和(2.02±0.55)×10^9/L,其中血清瘦素水平与BMI呈正相关(r=0.561,P=0.006),与清蛋白、淋巴细胞数无相关性(r=0.206,P=0.242;r=0.122,P=0.412),不同临床分期间及有无淋巴结转移者间血清瘦素水平差异均无统计学意义(F=1.325,P=0.281;t=-0.595,P=0.556)。Logistic回归分析显示,随瘦素水平的增高食管鳞状细胞癌的发病危险性升高(OR=1.442,P=0.009)。结论瘦素水平的升高可能是食管鳞状细胞癌发生的一个危险因子。 Objective To explore the relationship of serum leptin concentration, body mass index (BMI) and esophageal squamous cell carcinoma. Methods Blood samples were collected from 47 patients with esophageal squamous cell carcinoma and 20 healthy controls in Shanxi Cancer Hospital. Serum leptin was measured by ELISA. Results Serum leptin concentration in patients group was significantly higher than control group [(13.09±5.94) ng/ml vs (7.58±4.16) ng/ml, (t = 3.76, P=0.001)]. In 47 patients, BMI, albumin and lymphocytes were (25.20±3.14) kg/m2, (43.58±2.15)g/L and (2.02±0.55)×10^9/L, respectively. The serum leptin concentration of all patients (47 cases) were positive correlation with BMI (r = 0.561, P = 0.006), not with blood albumin and lymphocytes (r= 0.206, P = 0.242; r = 0.122, P= 0.412). Multiple logistic regression analysis reveal statistically significant association between serum leptin and esophageal squamous cell carcinoma incidence (OR =1.442, 95 % CI 1.094-1.848, P = 0.09). Conclusion Higher serum leptin levels seem to represent an additional and independent risk factor for esophageal squamous cell carcinoma.
出处 《肿瘤研究与临床》 CAS 2011年第11期759-761,共3页 Cancer Research and Clinic
关键词 瘦素 人体质量指数 食管肿瘤 肿瘤 鳞状细胞 Leptin Body mass index Esophageal neoplasms Neoplasms, squamous cell
  • 相关文献

参考文献23

  • 1Zhang F, Chen Y, Heiman M, et al. Leptin: structure, function and biology. Vitam Horm, 2005, 71: 345-372.
  • 2Yin N, Wang D, Zhang H, et al. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res, 2004, 64: 5870-5875.
  • 3Chen C, Chang YC, Liu CL, et al. Leptin - induced growth of human ER-75-1 breast cancer ceils is associated with upregulation of cyclin D1 and c-Myc and down-regu|ation of tumor suppressor p53 and p21 WAF1/CIP1. Breast Cancer Res Treat, 2006, 98: 121-132.
  • 4Somasundar P, Riggs D, Jackson B, et al. Leptin stimulatesesophageal adenocarcinoma growth by nonapoptotic mechanisms. Am J Surg, 2003, 5: 575-578.
  • 5Beales IL, Ogunwobi OO. Leptin synergistically enhances the anti- apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Mol Cell Endocrinol, 2007, 274: 60- 68.
  • 6Pal R, Lin C, Tran T, et al. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Biochem Biophys Res Commun, 2005, 331: 984-992.
  • 7Sukhotnik I, Vadasz Z, Coran AG, et al. Effect of leptin on intestinal re-growth following massive small bowel resection in rat. Pediatr Surg Int, 2006, 22: 9-15.
  • 8Hoda MR, Keely SJ, Bertelsen LS, et al. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg, 2007, 94: 346- 354.
  • 9Diakowska D, Krzystek-Korpacka M, Markocka-Maczka K, et al. Circulating leptin and inflammatory response in esophageal cancer, esophagealcancer-related cachexia-anorexia syndrome (CAS) and non- malignant CAS of the alimentary tract. Cytokine, 2010, 51: 132-137.
  • 10罗南萍,刘恒国,孙晓明,陈英剑.不同肿瘤患者leptin与NPY关系的研究[J].放射免疫学杂志,2008,21(3):197-199. 被引量:7

二级参考文献43

共引文献589

同被引文献49

  • 1Edward O.Adeyemi,Salim A.Bastaki,Irwin S.Chandranath,Mohammed Y.Hasan,Mohammed Fahim,Abdu Adem.Mechanisms of action of leptin in preventing gastric ulcer[J].World Journal of Gastroenterology,2005,11(27):4154-4160. 被引量:9
  • 2侯振江,王秀文,张丽华,周秀艳,戴殿禄,闫金辉.肝细胞癌患者血清瘦素表达及其临床意义[J].中国现代医药杂志,2007,9(5):5-8. 被引量:5
  • 3Zhang Y,Maffei M,Barone M,et al. Positional cloning of the mouseobese gene and its human homologue. Nature, 1994,372:425- 432.
  • 4Chu N F,Spiegelman D, Hotamisligil G S,et al. Plasma Insulin, leptin, and soluble TNF receptors levels in relation to obesity- relatedatherogenie and thrombogenic cardiovascul,disease risk factors among men. Atherosdemsis, 2001,157 : 495-503.
  • 5Gary W. Falk, Risk Factors for esophageal adenocarcinoma. Surg Oncol Chn North Am,2009,18: 469-485.
  • 6Enzinger P C, Mayer R J. Esophageal cancer.N Engl J Med, 2003 349,2241-2252.
  • 7Abner CC, Freedman ND, Hollenbeck AR, et al. A prospective study of BMI andrisk of oesophageal and gastric adenocarcinoma. Eur J Cancer, 2008;44:465-471.
  • 8Merry AH, Schouten LJ, Goldbohm RA, et al. Body mass index, height and riskof adenocarcinoma of the oesophagus and gastric cardia: a prospective cohortstudy. Gut, 2007, 56:1503-1511.
  • 9Engeland A, Tretli S, Bj d~ rge T. Height and body mass index in relation to esophagealcancer; 23-year follow-up of two million Norwegian men and women.Cancer Causes Control, 2004, 15:837- 843.
  • 10Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors forgastroesopbageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.Dis Esophagus, 2006, 19:321-328.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部